The Synthesis research library

Conviction needs
a foundation

Every great investment begins with an edge. Uncover the signals, understand the risks, and turn market complexity into the clarity you need to build lasting wealth.

Company filingsProprietary frameworkAutomated validation

Inside the library

A view you can examine.

One public excerpt.
The complete picture is for members.

A selected excerpt from published research. Concealed rows are placeholders; their research is available inside the member library.

Inside the research

An investment case,
in miniature.

One company. The opportunity, the counterargument, and what they mean for an investor.

Intuitive Surgical

ISRG · Surgical robotics

A great business is only half
the investment case.

The opportunity

A da Vinci robot starts a relationship that can last well beyond the initial sale. Each procedure creates demand for instruments and accessories, while hospitals also pay for service. Instruments and accessories alone supplied roughly 60% of revenue in 2025. More procedures can therefore mean more repeat sales from the systems already in place. That is the engine behind the business’s appeal.

The catch

Business quality does not settle the question of price. Our report finds a strong franchise, but shares priced for demanding future cash generation. When investors pay for years of rapid growth in advance, even solid operating progress can leave little room for attractive returns.

What could change the picture

Competing surgical systems could take procedures or force lower prices. If procedure growth slows while margins weaken, the cash generated by that installed base could fall short of expectations. The risk is not simply fewer new robot sales; it is weaker economics across the business that follows them.

The investment implication

In our base case, the business keeps growing. The investment question is whether that growth is enough to justify the price already being paid. A slower-growth outcome would make that price harder to support; stronger growth could improve the return. The distinction matters: admiring the company and buying its shares are separate decisions.

Company facts and competitive risks:2025 annual report · Business & risks

Investment interpretation: Synthesis’s dated report. This selected case is condensed; the full report includes additional risks and assumptions.

This is the outline.
Membership opens the complete case.

Explore the valuation, downside and upside scenarios, supporting evidence, and the conditions that would change our view.

Explore membership

How the work earns your trust

The research does the work.
You can examine the reasoning.

01 / Source

Begin with the record.

Company filings anchor the investigation. The reports preserve the evidence behind their claims, so the source stays close to the conclusion.

Where the evidence starts ↗
02 / Investigate

Give every view a standard.

A proprietary research framework guides the assessment. Automated validation checks the resulting work before it enters the library.

Examine the method ↗
03 / Question

Show what could change.

The research sets out its assumptions, scenarios and the conditions that would change its view. Members get the reasoning alongside the result.

Explore the library ↗

Stated before the outcome

A considered view.
With its limits in view.

Our stated expectation is that about four in ten Strong or Sound verdicts will trail the S&P 500 over five years.

This is a base-rate assumption. A measured track record has not yet been published. AI can make mistakes; sources, assumptions and limits are part of every assessment.

Read the limits

Before you join

Good research
invites questions.

Our approach is explained openly.
The research is for members.

What makes this research proprietary?

The filings are available to everyone. Synthesis builds its own analysis from them: company assessments, valuations, scenarios and the conditions that would change a conclusion. That research belongs to the member library.

What role does AI play?

AI agents investigate companies using a research framework. Automated checks test the resulting reports against that method before publication. The work is produced by AI; it is not presented as analysis written or approved by a human analyst.

What can I see before joining?

Our public overview explains the research approach and its limits. The detailed scoring framework is proprietary. This page includes one selected research excerpt. The complete rankings, reports, valuations, evidence and history require research access.

How should I assess a report?

Read its sources and assumptions, check its dates, and consider the conditions that would change its conclusions. AI can make mistakes. A report is a reasoned view to examine, and its limits are part of the work.

Is this personal investment advice?

Synthesis publishes impersonal company research. Members receive the same analysis, which does not consider anyone’s financial circumstances or objectives.

Your own view starts with the work

Read the reasoning.
Make up your own mind.

The complete Synthesis research library, for members.

Explore membership